Research Intelligence · Launching Soon

The intelligence layer for peptide and longevity research.

Peptivex transforms scientific literature, clinical trials, and biomedical research into clear, citation-first intelligence for peptides, GLP-1s, and emerging longevity compounds.

What Peptivex does

A research-first platform built around citations, evidence transparency, and conservative framing.

Compound Database

Search peptides, GLP-1s, metabolic therapies, and longevity compounds in one research-first library.

Evidence Scoring

Understand where evidence is strongest, limited, emerging, or preclinical.

Clinical Trial Tracking

Follow active, completed, and emerging studies tied to compounds and conditions.

AI Research Copilot

Ask what the research says without crossing into dosing, diagnosis, or treatment guidance.

Research Comparisons

Compare compounds side by side across mechanisms, evidence tiers, safety context, and trial activity.

Saved Research Boards

Organize compounds, citations, and research questions into reusable boards.

Join the Peptivex Early Access List

Get notified when Peptivex launches and help shape the future of peptide and longevity research intelligence.

Request Early Access

Get notified when Peptivex launches.

By submitting, you confirm you are 18 or older. We will email you about Peptivex launches and updates. You can unsubscribe at any time.

Peptivex is for research and educational purposes only. It does not provide medical advice, diagnosis, treatment guidance, prescribing recommendations, or dosing instructions.